Breaking News, Financial News

Financial Report: Covance

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Covance 2Q Revenues: $335 million (+14%) 2Q Earnings: $35 million (+32%) YTD Revenues: $656 million (+14%) YTD Earnings: $68 million (+32%) Comments: The company achieved record net orders of $555 million in the quarter, driving its backlog up 31% to nearly $2 billion. Early development revenues for the quarter grew 11% to $156 million and operating income increased 16% to $39 million in the quarter. Late-stage development revenues were up 16% to $179.5 million and operatin...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters